http://www.newstin.com/us/LAZARD Organizing the News Copyright © 2006 I2S a.s. Copyright © 2006 I2S a.s. http://www.newstin.com/tag/us/89069759 November 20, 2008 | about stocks: Executives Dominic Orr – President, CEO Steffan Tomlinson, Chief Financial Officer Keerti Melkote – Founder, Chief Technology Officer Analysts Jeffrey Kvall – Barclays Capital Eric Suppiger –... Fri, 21 Nov 2008 05:17:41 GMT http://www.newstin.com/tag/us/89069759 2008-11-21T05:17:41Z http://www.newstin.com/tag/us/89099854 November 21, 2008 | about stocks: Q3 2008 Earnings Call Transcript Executives Marco Benedetti – Corporate Controller Thomas Hook – President and CEO Thomas Mazza – SVP and CFO Analysts Jamar Ismail – Canaccord Adams Tim Lee –... Fri, 21 Nov 2008 07:19:17 GMT http://www.newstin.com/tag/us/89099854 2008-11-21T07:19:17Z http://www.newstin.com/tag/us/88974224 NEW YORK----The Board of Directors of Lazard Global Total Return & Income Fund has authorized the Fund to declare today, a distribution of $0.2807 per share on the company’s outstanding common stock. Thu, 20 Nov 2008 17:31:32 GMT http://www.newstin.com/tag/us/88974224 2008-11-20T17:31:32Z http://www.newstin.com/tag/us/88962445 WASHINGTON - Shares of Targanta Therapeutics Corp. plunged Thursday, a day after a panel of government experts voted against the benefits of the company's antibiotic. On Wednesday the Food and Drug Administration's panel of... Thu, 20 Nov 2008 16:08:27 GMT http://www.newstin.com/tag/us/88962445 2008-11-20T16:08:27Z http://www.newstin.com/tag/us/88978365 November 20, 2008 | about stocks: Q3 2008 Earnings Call Transcript Executives Don DeBethizy – President and CEO Alan Musso – CFO, VP, Treasurer, and Assistant Secretary Analysts Terence Flynn – Lazard Capital Markets Bret... Thu, 20 Nov 2008 17:59:20 GMT http://www.newstin.com/tag/us/88978365 2008-11-20T17:59:20Z http://www.newstin.com/tag/us/88993430 Wall Street brushed off Amgen Inc.'s suspension of enrollment in a cancer drug study Thursday, saying the developing treatment motesanib is not expected to be a key part of the biotechnology company's future revenue. Thu, 20 Nov 2008 19:37:43 GMT http://www.newstin.com/tag/us/88993430 2008-11-20T19:37:43Z http://www.newstin.com/tag/us/88993619 by: theflyonthewall.com November 20, 2008 | about stocks: ) is expected to report Q3 earnings after market close Thursday, November 20, with a conference call scheduled for 5:00 pm ET. Guidance The consensus estimate is 7c for... Thu, 20 Nov 2008 19:38:56 GMT http://www.newstin.com/tag/us/88993619 2008-11-20T19:38:56Z http://www.newstin.com/tag/us/88967528 Intuitive Surgical, Inc. (NASD:ISRG) has been a favorite stock for traders. Daily Chart with InVivo Swing Trading Tools There are a number of the reasons why the momentum players like ISRG; High priced stock with lots of... Thu, 20 Nov 2008 15:38:00 GMT http://www.newstin.com/tag/us/88967528 2008-11-20T15:38:00Z http://www.newstin.com/tag/us/88993295 November 20, 2008 | about stocks: E-House (China) Holdings Limited Q3 2008 Earnings Call Transcript Executives Michelle Yuan – Manager, IR Xin Zhou – Chairman and CEO Li-Lan Cheng – CFO Analysts Colin Sebastian – Lazard Capital... Thu, 20 Nov 2008 19:36:47 GMT http://www.newstin.com/tag/us/88993295 2008-11-20T19:36:47Z http://www.newstin.com/tag/us/88975678 Obesity drug developers may have trouble getting drugs reimbursed by private and government health plans, though physicians will likely be enthusiastic about the treatments, said Lazard Capital Markets. Thu, 20 Nov 2008 17:41:07 GMT http://www.newstin.com/tag/us/88975678 2008-11-20T17:41:07Z